| Reisman, Mark |
NCT04890821: Early Feasibility Study of the Cardiac Implants Percutaneous Ring Annuloplasty System |
|
|
| Recruiting | N/A | 15 | US | CI Percutaneous Ring Annuloplasty System | Cardiac Implants LLC | Tricuspid Regurgitation Functional | 08/22 | 09/27 | | |
CorCinch-HF, NCT04331769: Clinical Evaluation of the AccuCinch® Ventricular Restoration System in Patients Who Present with Symptomatic Heart Failure with Reduced Ejection Fraction (HFrEF): the CORCINCH-HF Study |
|
|
| Recruiting | N/A | 400 | Europe, US, RoW | AccuCinch Ventricular Restoration System, Guideline-Directed Medical Therapy | Ancora Heart, Inc. | Heart Failure with Reduced Ejection Fraction (HFrEF), Dilated Cardiomyopathy | 12/26 | 12/30 | | |
| Active, not recruiting | N/A | 1070 | Europe, US | Edwards EVOQUE System, Transcatheter tricuspid valve replacement, Optimal Medical Therapy | Edwards Lifesciences | Tricuspid Valve Regurgitation, Tricuspid Valve Insufficiency, Tricuspid Valve Disease, Heart Valve Diseases, Cardiovascular Diseases, Heart Failure | 06/24 | 12/29 | | |
NCT06212193: Innoventric Trillium™ Stent Graft Early Feasibility Study (EFS) |
|
|
| Recruiting | N/A | 15 | US | Trillium™ | Innoventric LTD, Innoventric Inc. | Tricuspid Regurgitation, Tricuspid Regurgitation Functional | 08/25 | 08/30 | | |
| Recruiting | N/A | 870 | Canada, US | Edwards PASCAL System, Transcatheter tricuspid valve repair (TTVr), Optimal Medical Therapy | Edwards Lifesciences | Tricuspid Regurgitation, Tricuspid Valve Insufficiency, Tricuspid Valve Disease | 12/27 | 12/31 | | |
NCT03142152: The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With at Least Mild FMR |
|
|
| Recruiting | N/A | 300 | Europe, US | Carillon Mitral Contour System, Carillon, Percutaneous mitral valve repair, Guideline Directed Heart Failure Medication | Cardiac Dimensions, Inc. | Functional Mitral Regurgitation, Heart Failure, Mitral Valve Insufficiency, Heart Diseases, Cardiovascular Diseases, Heart Valve Diseases | 12/26 | 12/30 | | |
| Domoto-Reilly, Kimiko |
NCT03260920: Intranasal Oxytocin for Frontotemporal Dementia |
|
|
| Active, not recruiting | 2 | 112 | Canada, US | Syntocinon, Intranasal Oxytocin | Lawson Health Research Institute, Weston Brain Institute, Canadian Institutes of Health Research (CIHR), Berry Consultants | Frontotemporal Dementia | 06/23 | 12/24 | | |
SHIMMER, NCT05225415: Study to Evaluate the Safety, Tolerability and Efficacy of CT1812 in Subjects with Mild to Moderate Dementia with Lewy Bodies |
|
|
| Completed | 2 | 130 | US | CT1812 | Cognition Therapeutics, National Institute on Aging (NIA) | Dementia with Lewy Bodies | 11/24 | 11/24 | | |
NCT04363684: ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD) |
|
|
| Recruiting | N/A | 2100 | Canada, US | | Mayo Clinic, University of California, San Francisco, National Institute on Aging (NIA), National Institute of Neurological Disorders and Stroke (NINDS) | Frontotemporal Lobar Degeneration (FTLD), Progressive Supranuclear Palsy (PSP), Corticobasal Degeneration (CBD), Behavioral Variant Frontotemporal Dementia (bvFTD), Semantic Variant Primary Progressive Aphasia (svPPA), Nonfluent Variant Primary Progressive Aphasia (nfvPPA), FTD With Amyotrophic Lateral Sclerosis (FTD/ALS), Amyotrophic Lateral Sclerosis, Oligosymptomatic PSP (oPSP), C9orf72, GRN Related Frontotemporal Dementia, MAPT Gene Mutation, TBK1 Gene Mutation, Oligosymptomatic Progressive Supranuclear Palsy | 06/25 | 06/25 | | |
| Gore, John L |
TURBT, NCT06111235: A Study of Adjuvant Cretostimogene Grenadenorepvec for Treatment of Intermediate Risk NMIBC Following |
|
|
| Recruiting | 3 | 364 | Canada, US | Cretostimogene Grenadenorepvec, CG0070, n-dodecyl-B-D-maltoside, DDM | CG Oncology, Inc. | Non Muscle Invasive Bladder Cancer, Urologic Cancer, Bladder Cancer, Urothelial Carcinoma | 01/28 | 01/30 | | |
NCT06422312: A Study Comparing a Disposable Flexible Cystoscope With Reusable Scopes in Adult Patients. |
|
|
| Not yet recruiting | N/A | 140 | US | Cystoscopy with RedPine flexible disposable cystoscope, Cystoscopy with standard of care flexible reusable scope | Guangzhou Red Pine Medical Instrument Co., Ltd., University of Texas Southwestern Medical Center, University of Washington, Penn State University | Bladder Cancer, Bladder Stone, Bladder Outlet Obstruction, Renal Stone, Renal Disease | 01/25 | 07/25 | | |
CISTO, NCT03933826: Comparison of Intravesical Therapy and Surgery as Treatment Options for Bladder Cancer |
|
|
| Active, not recruiting | N/A | 572 | US | | University of Washington, Patient-Centered Outcomes Research Institute | Bladder Cancer, Cancer of the Bladder, Recurrent, Non-muscle Invasive Bladder Cancer | 12/24 | 03/25 | | |
| Not yet recruiting | N/A | 260 | US | STRIVE Peer Support Intervention | Oregon Health and Science University, Patient-Centered Outcomes Research Institute, NYU Langone Health, Rush University, University of Utah, University of Minnesota, Temple University, University of California, San Francisco, University of Washington, Trans Lifeline, Whitman-Walker Institute, Duke University | Gender Affirmation Surgery, Perioperative Care, Transgender Health | 09/28 | 12/28 | | |
| Recruiting | N/A | 4400 | US | Hexaminolevulinate hydrochloride (HCL), Cysview®, Hexvix®, Karl Storz D-Light C Photodynamic Diagnostic (PDD) system | Photocure, Catalyst Pharmaceutical Research | Bladder Cancer | 12/28 | 12/28 | | |
| Jordan, Kate |
NCT03142152: The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With at Least Mild FMR |
|
|
| Recruiting | N/A | 300 | Europe, US | Carillon Mitral Contour System, Carillon, Percutaneous mitral valve repair, Guideline Directed Heart Failure Medication | Cardiac Dimensions, Inc. | Functional Mitral Regurgitation, Heart Failure, Mitral Valve Insufficiency, Heart Diseases, Cardiovascular Diseases, Heart Valve Diseases | 12/26 | 12/30 | | |
| Dirks, Annie |
| Recruiting | 4 | 250 | US | Bromocriptine, Parlodel, Cycloset, Placebo, Guideline Directed Medical Therapy for Heart Failure (GDMT), Rivaroxaban, Xarelto, Second Placebo | Dennis M. McNamara, MD, MS, National Heart, Lung, and Blood Institute (NHLBI) | Peripartum Cardiomyopathy, Postpartum | 06/26 | 12/28 | | |
MUSIC-HFrEF1, NCT04703842: Modulation of SERCA2a of Intra-myocytic Calcium Trafficking in Heart Failure With Reduced Ejection Fraction |
|
|
| Recruiting | 1/2 | 57 | US | SRD-001, Placebo | Sardocor Corp., Covance | Congestive Heart Failure, Heart Failure, Systolic, Heart Failure, HFrEF - Heart Failure With Reduced Ejection Fraction | 12/25 | 12/28 | | |
| Grodzinsky, Anna |
| Recruiting | 4 | 250 | US | Bromocriptine, Parlodel, Cycloset, Placebo, Guideline Directed Medical Therapy for Heart Failure (GDMT), Rivaroxaban, Xarelto, Second Placebo | Dennis M. McNamara, MD, MS, National Heart, Lung, and Blood Institute (NHLBI) | Peripartum Cardiomyopathy, Postpartum | 06/26 | 12/28 | | |
| Recruiting | N/A | 135 | US | CardioFlux | Genetesis Inc. | Ischemic Heart Disease, Coronary Microvascular Disease, Angina, Myocardial Ischemia | 12/24 | 12/24 | | |
NCT04828070: The Heart Outcomes in Pregnancy Expectations (H.O.P.E) Registry |
|
|
| Active, not recruiting | N/A | 75 | US | Observation | Saint Luke's Health System, Massachusetts General Hospital | Pregnancy Related, Cardiac Disease | 06/25 | 06/26 | | |
| Recruiting | N/A | 1000 | US, RoW | | SCAD Alliance, PERFUSE Study Group | Spontaneous Coronary Artery Dissection | 12/25 | 12/25 | | |
| Nakamura, Kenta |
MUSIC-HFrEF1, NCT04703842: Modulation of SERCA2a of Intra-myocytic Calcium Trafficking in Heart Failure With Reduced Ejection Fraction |
|
|
| Recruiting | 1/2 | 57 | US | SRD-001, Placebo | Sardocor Corp., Covance | Congestive Heart Failure, Heart Failure, Systolic, Heart Failure, HFrEF - Heart Failure With Reduced Ejection Fraction | 12/25 | 12/28 | | |
| Wong, Susan P |
NCT06411613: Home-based Conservative Care Model for Advanced Kidney Disease |
|
|
| Recruiting | N/A | 30 | US | CC Program | VA Office of Research and Development | Chronic Kidney Diseases | 07/27 | 12/30 | | |
| Recruiting | N/A | 76 | US | CKM Jumpstart Tool | University of Washington | Chronic Kidney Diseases | 12/24 | 12/25 | | |
NCT05789316: Head and Neck Cancer Survivorship Ototoxicity Screening (SOS) |
|
|
| Recruiting | N/A | 60 | US | Ototoxicity Screening Protocol | Washington University School of Medicine, American Academy of Otolaryngology-Head and Neck Surgery Foundation | Head and Neck Cancer Survivors, Cancer of the Head and Neck Surviors | 12/25 | 12/25 | | |
| Smith, Armine K |
NCT06525571: Outcomes of High-risk Non-muscle Invasive Bladder Cancer Treated With Blue Light Resection |
|
|
| Recruiting | 3 | 200 | US | Cysview, Hexyl aminolevulinate (HAL), Karl Storz D-Light C Photodynamic Diagnostic (PDD) system, Cystoscopy equipment to detect Cysview uptake in the bladder tumors | Johns Hopkins University, Photocure ASA | Bladder Cancer | 01/27 | 01/28 | | |
NCT05399004: Evaluating Sexual Function in Women Undergoing a Radical Cystectomy for Bladder Cancer |
|
|
| Completed | N/A | 34 | NA | Survey Administration | Mayo Clinic, National Cancer Institute (NCI) | Bladder Carcinoma | 06/24 | 06/24 | | |
NCT05649306: Gender Related Coping and Survivorship for Genitourinary Cancers |
|
|
| Recruiting | N/A | 80 | US | Additional Education, Questionnaires, Attendance Diary | Johns Hopkins University | Bladder Cancer | 09/25 | 09/26 | | |
NCT05672615: Mood Alterations in the Patients With Non-Muscle Invasive Bladder Cancer Treated With BCG |
|
|
| Recruiting | N/A | 42 | US | Questionnaires, Daily Mood Diaries, Urine Specimen Collection, Research Blood Draw, Utilize excess tissue from a standard of care procedure | Johns Hopkins University | Non-Muscle Invasive Bladder Cancer | 03/25 | 03/28 | | |
NCT05792722: Evaluating Safety and Efficacy of Prostate-sparing Radical Cystectomy |
|
|
| Recruiting | N/A | 70 | US | Prostate capsule-sparing radical cystectomy, Nerve sparing radical cystectomy | Johns Hopkins University | Bladder Cancer | 07/26 | 07/26 | | |
| Recruiting | N/A | 4400 | US | Hexaminolevulinate hydrochloride (HCL), Cysview®, Hexvix®, Karl Storz D-Light C Photodynamic Diagnostic (PDD) system | Photocure, Catalyst Pharmaceutical Research | Bladder Cancer | 12/28 | 12/28 | | |
| Nassans, Katherine |
GenePHIT, NCT05598333: Phosphatase Inhibition by Intracoronary Gene Therapy in Subjects with Non-Ischemic NYHA Class III Heart Failure |
|
|
| Recruiting | 2 | 150 | US | AB-1002, Gene Therapy, NAN-101 | Asklepios Biopharmaceutical, Inc. | Congestive Heart Failure | 10/26 | 12/30 | | |
MUSIC-HFrEF1, NCT04703842: Modulation of SERCA2a of Intra-myocytic Calcium Trafficking in Heart Failure With Reduced Ejection Fraction |
|
|
| Recruiting | 1/2 | 57 | US | SRD-001, Placebo | Sardocor Corp., Covance | Congestive Heart Failure, Heart Failure, Systolic, Heart Failure, HFrEF - Heart Failure With Reduced Ejection Fraction | 12/25 | 12/28 | | |
